vs
Cytek Biosciences, Inc.（CTKB）与FS Bancorp, Inc.（FSBW）财务数据对比。点击上方公司名可切换其他公司
Cytek Biosciences, Inc.的季度营收约是FS Bancorp, Inc.的1.6倍（$62.1M vs $40.0M），FS Bancorp, Inc.同比增速更快（12.0% vs 8.1%），FS Bancorp, Inc.自由现金流更多（$51.9M vs $-1.8M），过去两年Cytek Biosciences, Inc.的营收复合增速更高（17.7% vs 6.2%）
Cytek Biosciences主营高性能流式细胞分析系统、配套试剂及分析软件的研发、生产与商业化，产品服务覆盖生命科学研究、临床诊断、生物制药开发等领域，客户遍及全球多个主要地区。
FS Bancorp, Inc.是总部位于美国的银行控股公司，为华盛顿第一安全银行的母公司，主要面向美国太平洋西北地区客户提供各类个人及商业银行服务，包括存款产品、住房贷款、小微企业融资、建筑贷款等，核心业务涵盖零售银行、商业银行及住房信贷三大板块。
CTKB vs FSBW — 直观对比
营收规模更大
CTKB
是对方的1.6倍
$40.0M
营收增速更快
FSBW
高出3.9%
8.1%
自由现金流更多
FSBW
多$53.7M
$-1.8M
两年增速更快
CTKB
近两年复合增速
6.2%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $62.1M | $40.0M |
| 净利润 | $-44.1M | — |
| 毛利率 | 52.9% | — |
| 营业利润率 | -9.0% | 25.8% |
| 净利率 | -70.9% | — |
| 营收同比 | 8.1% | 12.0% |
| 净利润同比 | -557.1% | — |
| 每股收益（稀释后） | — | $1.11 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CTKBFSBW
| Q4 25 | $62.1M | $40.0M | ||
| Q3 25 | $52.3M | $39.3M | ||
| Q2 25 | $45.6M | $37.3M | ||
| Q1 25 | $41.5M | $36.1M | ||
| Q4 24 | $57.5M | $35.7M | ||
| Q3 24 | $51.5M | $37.2M | ||
| Q2 24 | $46.6M | $36.3M | ||
| Q1 24 | $44.9M | $35.5M |
净利润CTKBFSBW
| Q4 25 | $-44.1M | — | ||
| Q3 25 | $-5.5M | $9.2M | ||
| Q2 25 | $-5.6M | $7.7M | ||
| Q1 25 | $-11.4M | $8.0M | ||
| Q4 24 | $9.6M | — | ||
| Q3 24 | $941.0K | $10.3M | ||
| Q2 24 | $-10.4M | $9.0M | ||
| Q1 24 | $-6.2M | $8.4M |
毛利率CTKBFSBW
| Q4 25 | 52.9% | — | ||
| Q3 25 | 52.7% | — | ||
| Q2 25 | 52.3% | — | ||
| Q1 25 | 48.6% | — | ||
| Q4 24 | 58.5% | — | ||
| Q3 24 | 56.3% | — | ||
| Q2 24 | 54.6% | — | ||
| Q1 24 | 51.3% | — |
营业利润率CTKBFSBW
| Q4 25 | -9.0% | 25.8% | ||
| Q3 25 | -17.6% | 29.5% | ||
| Q2 25 | -23.3% | 26.2% | ||
| Q1 25 | -36.1% | 26.2% | ||
| Q4 24 | 5.2% | 27.6% | ||
| Q3 24 | -8.2% | 26.5% | ||
| Q2 24 | -18.3% | 31.3% | ||
| Q1 24 | -23.9% | 29.7% |
净利率CTKBFSBW
| Q4 25 | -70.9% | — | ||
| Q3 25 | -10.5% | 23.4% | ||
| Q2 25 | -12.2% | 20.7% | ||
| Q1 25 | -27.5% | 22.2% | ||
| Q4 24 | 16.8% | — | ||
| Q3 24 | 1.8% | 27.6% | ||
| Q2 24 | -22.4% | 24.7% | ||
| Q1 24 | -13.8% | 23.7% |
每股收益（稀释后）CTKBFSBW
| Q4 25 | — | $1.11 | ||
| Q3 25 | — | $1.18 | ||
| Q2 25 | — | $0.99 | ||
| Q1 25 | — | $1.01 | ||
| Q4 24 | — | $0.88 | ||
| Q3 24 | — | $1.29 | ||
| Q2 24 | — | $1.13 | ||
| Q1 24 | — | $1.06 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $90.9M | $28.2M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $341.7M | $307.7M |
| 总资产 | $461.5M | $3.2B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资CTKBFSBW
| Q4 25 | $90.9M | $28.2M | ||
| Q3 25 | $93.3M | $61.3M | ||
| Q2 25 | $75.5M | $33.2M | ||
| Q1 25 | $95.3M | $62.7M | ||
| Q4 24 | $98.7M | $31.6M | ||
| Q3 24 | $162.3M | $40.3M | ||
| Q2 24 | $177.9M | $33.0M | ||
| Q1 24 | $168.8M | $45.4M |
股东权益CTKBFSBW
| Q4 25 | $341.7M | $307.7M | ||
| Q3 25 | $378.6M | $300.5M | ||
| Q2 25 | $377.6M | $297.2M | ||
| Q1 25 | $379.6M | $298.8M | ||
| Q4 24 | $395.7M | $295.8M | ||
| Q3 24 | $385.5M | $288.9M | ||
| Q2 24 | $389.1M | $284.0M | ||
| Q1 24 | $392.6M | $277.9M |
总资产CTKBFSBW
| Q4 25 | $461.5M | $3.2B | ||
| Q3 25 | $494.9M | $3.2B | ||
| Q2 25 | $493.3M | $3.2B | ||
| Q1 25 | $482.6M | $3.1B | ||
| Q4 24 | $499.5M | $3.0B | ||
| Q3 24 | $491.2M | $3.0B | ||
| Q2 24 | $483.7M | $2.9B | ||
| Q1 24 | $492.1M | $3.0B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-771.0K | $72.3M |
| 自由现金流经营现金流 - 资本支出 | $-1.8M | $51.9M |
| 自由现金流率自由现金流/营收 | -2.9% | 129.8% |
| 资本支出强度资本支出/营收 | 1.6% | 50.9% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-8.8M | $107.2M |
8季度趋势，按日历期对齐
经营现金流CTKBFSBW
| Q4 25 | $-771.0K | $72.3M | ||
| Q3 25 | $-3.9M | $44.6M | ||
| Q2 25 | $108.0K | $7.1M | ||
| Q1 25 | $-125.0K | $8.2M | ||
| Q4 24 | $2.0M | $50.8M | ||
| Q3 24 | $13.2M | $-891.0K | ||
| Q2 24 | $6.2M | $9.9M | ||
| Q1 24 | $4.0M | $275.0K |
自由现金流CTKBFSBW
| Q4 25 | $-1.8M | $51.9M | ||
| Q3 25 | $-4.6M | $41.6M | ||
| Q2 25 | $-1.5M | $5.9M | ||
| Q1 25 | $-974.0K | $7.8M | ||
| Q4 24 | $1.1M | $49.2M | ||
| Q3 24 | $12.2M | $-1.5M | ||
| Q2 24 | $5.2M | $9.6M | ||
| Q1 24 | $3.4M | $-82.0K |
自由现金流率CTKBFSBW
| Q4 25 | -2.9% | 129.8% | ||
| Q3 25 | -8.7% | 105.9% | ||
| Q2 25 | -3.2% | 15.7% | ||
| Q1 25 | -2.3% | 21.7% | ||
| Q4 24 | 1.9% | 137.7% | ||
| Q3 24 | 23.7% | -4.1% | ||
| Q2 24 | 11.0% | 26.6% | ||
| Q1 24 | 7.6% | -0.2% |
资本支出强度CTKBFSBW
| Q4 25 | 1.6% | 50.9% | ||
| Q3 25 | 1.3% | 7.7% | ||
| Q2 25 | 3.5% | 3.5% | ||
| Q1 25 | 2.0% | 1.0% | ||
| Q4 24 | 1.6% | 4.6% | ||
| Q3 24 | 2.0% | 1.7% | ||
| Q2 24 | 2.3% | 0.8% | ||
| Q1 24 | 1.3% | 1.0% |
现金转化率CTKBFSBW
| Q4 25 | — | — | ||
| Q3 25 | — | 4.86× | ||
| Q2 25 | — | 0.92× | ||
| Q1 25 | — | 1.02× | ||
| Q4 24 | 0.21× | — | ||
| Q3 24 | 14.05× | -0.09× | ||
| Q2 24 | — | 1.11× | ||
| Q1 24 | — | 0.03× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CTKB
| Products | $46.6M | 75% |
| Services | $15.5M | 25% |
FSBW
暂无分部数据
